State Of Wyoming Amneal Pharmaceuticals, Inc. Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wyoming holds 42,636 shares of AMRX stock, worth $383,724. This represents 0.05% of its overall portfolio holdings.

Number of Shares

42,636

Previous 52,752 19.18%

Holding current value

$383,724

Previous $334,000 5.99%

% of portfolio

0.05%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $64,944 - $89,324	-10,116 Reduced 19.18%	42,636 $354,000
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $28,804 - $38,209	-5,374 Reduced 9.25%	52,752 $334,000
Q1 2024 May 13, 2024	SELL	$5.24 - $6.34 $118,481 - $143,353	-22,611 Reduced 28.01%	58,126 $352,000
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $27,081 - $50,052	8,060 Added 11.09%	80,737 $490,000
Q3 2023 Nov 14, 2023	SELL	$2.76 - $4.59 $55,456 - $92,226	-20,093 Reduced 21.66%	72,677 $306,000
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $9,500 - $22,143	7,143 Added 8.34%	92,770 $287,000
Q1 2023 May 12, 2023	BUY	$1.27 - $2.7 $11,898 - $25,296	9,369 Added 12.29%	85,627 $119,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $47,692 - $63,509	24,333 Added 46.86%	76,258 $151,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $48,090 - $86,181	23,807 Added 84.67%	51,925 $105,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $21,130 - $31,309	7,020 Added 33.27%	28,118 $89,000
Q1 2022 May 13, 2022	BUY	$3.9 - $4.89 $4,453 - $5,584	1,142 Added 5.72%	21,098 $88,000
Q4 2021 Feb 11, 2022	BUY	$3.95 - $5.85 $78,826 - $116,742	19,956 New	19,956 $96,000

Others Institutions Holding AMRX

# of Institutions

185

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.36B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account